Medicare to negotiate injected drug prices for 1st time
Digest more
Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...
Medicare lists cancer, arthritis, and HIV drugs for 2028 price negotiations, expanding its program to include Part B drugs administered in doctors' offices.
(Reuters) -CVS Health, which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, ...
Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...
The Food and Drug Administration has just approved a preventative HIV drug widely regarded as a breakthrough. On Wednesday afternoon, the FDA approved Gilead Sciences’ lenacapavir as a more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results